Farmacologia i Microbiologia Molecular

Jover-Sáenz, A; Santos Rodríguez C; Ramos Gil MÁ; Palomera Fernández M; Invencio da Costa LF; Torres-Puig-gros, J; Castellana Perelló D; Montiu González E; Schoenenberger-Arnaiz, JA; Bordalba Gómez JR; Galindo Ortego X; Ramirez-Hidalgo, M

Impact of an Antimicrobial Stewardship Strategy on Surgical Hospital Discharge: Improving Antibiotic Prescription in the Transition of Care.

Antibiotics-Basel 12 -. 30/04/2023.

[doi:10.3390/antibiotics12050834]

Stone, P; Buckle, P; Dolan, R; Feliu, J; Hui, D; Laird, BJA; Maltoni, M; Moine, S; Morita, T; Nabal, M; Vickerstaff, V; White, N; Santini, D; Ripamonti, CI

Prognostic evaluation in patients with advanced cancer in the last months of life: ESMO Clinical Practice Guideline

ESMO Open 8 1-13. 01/04/2023.

[doi:10.1016/j.esmoop.2023.101195]

Huerva V; Vilardell F; Cid-Bertomeu P

Cryotherapy after Topical Interferon Alpha 2b to Treat Conjunctival Primary Acquired Melanosis.

Case Reports in Ophthalmology 14 111-114. 22/03/2023.

[doi:10.1159/000529667]

Montellà-Manuel S; Pujol-Carrion N; de la Torre-Ruiz MA

Aft1 Nuclear Localization and Transcriptional Response to Iron Starvation Rely upon TORC2/Ypk1 Signaling and Sphingolipid Biosynthesis.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 24 -. 01/02/2023.

[doi:10.3390/ijms24032438]

Luis Recuero Díaz J; Almánzar SF; Munoz CG; Sierra JL; Porras ML; Medina DM; Vicuña MN; Moreno LS; Cantalejo MG; Porcel JM

Recommendations of the Spanish Society of Thoracic Surgery for the management of malignant pleural effusion.

CIRUGIA ESPANOLA 100 673-683. 01/11/2022.

[doi:10.1016/j.cireng.2022.06.009]

Cid-Bertomeu P; Huerva V

Use of interferon alpha 2b to manage conjunctival primary acquired melanosis and conjunctival melanoma.

SURVEY OF OPHTHALMOLOGY 67 1391-1404. 01/09/2022.

[doi:10.1016/j.survophthal.2022.03.003]

Huerva, V; Cid-Bertomeu, P; Espinet, R; Canto, LM

Adjunctive Treatment with Interferon Alpha 2b in Conjunctival Melanoma.

Ocular Oncology and Pathology 8 88-92. 01/06/2022.

[doi:10.1159/000522195]

Vilaltella, M; Vilardell, F; Cid-Bertomeu, P; Huerva, V

IgG(4)-related orbital disease

CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE 57 78-79. 01/06/2022.

Pujol-Carrion N; Gonzalez-Alfonso A; Puig S; de la Torre-Ruiz MA

Both human and soya bean ferritins highly improve the accumulation of bioavailable iron and contribute to extend the chronological life in budding yeast.

Microbial Biotechnology 15 1525-1541. 01/05/2022.

[doi:10.1111/1751-7915.13939]

Vilaltella, M; Huerva, V

The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size

ARQUIVOS BRASILEIROS DE OFTALMOLOGIA 85 109-114. 01/01/2022.

[doi:10.5935/0004-2749.20220018]

Martínez-Escardó L; Alemany M; Sánchez-Osuna M; Sánchez-Chardi A; Roig-Martínez M; Suárez-García S; Ruiz-Molina D; Vidal N; Plans G; Majós C; Ribas J; Baltrons MA; Bayascas JR; Barcia C; Bruna J; Yuste VJ

Gossypol Treatment Restores Insufficient Apoptotic Function of DFF40/CAD in Human Glioblastoma Cells.

Cancers 13 -. 08/11/2021.

[doi:10.3390/cancers13215579]

Taberner Bonastre P; Torres Vicente G; Cano-Marron M; Sese Abizanda E; Volta Pardo TD; Schoenenberger-Arnaiz JA

A patient with ulcerative colitis treated with a combination of vedolizumab and tofacitinib.

European Journal of Hospital Pharmacy 28 353-355. 01/11/2021.

[doi:10.1136/ejhpharm-2020-002437]